Beam Therapeutics advances base-editing pipeline with risto-cel studies and FDA designations, but no approved products and rising competition loom.

Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy according to analysts. On December 23, LifeSci Capital initiated coverage of Prime Medicine with an Outperform rating ...

Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.

After years of research, scientists in China have created a bone-free fish, which has been named 'Zhongke No. 6'. The new ...

Blockchain, nanomedicine, and 3D printing signal a growing emphasis on improving healthcare delivery through innovative ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.

For all of the political chaos that American science endured in 2025, aspects of this country’s research enterprise made it ...

Prime Medicine, Inc. (NASDAQ: PRME) is among the 12 Best Genomics Stocks to Invest In.

Two genetic innovations could address major welfare and productivity issues within the broiler and layer industries.

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...